Discontinue use if allergic or anaphylactic-type reactions occur; at 1st clinical sign of CV overload or increased BP, central venous pressure or pulmonary oedema. Hypervolaemia or haemodilution eg, CHF, HTN, oesophageal varices, pulmonary oedema, hemorrhagic diathesis, severe anaemia, renal or postrenal anuria. Patients on controlled Na diet. Monitor patient's electrolyte status. Ensure adequate substitution of other blood constituents in large vol replacement eg, coagulation factors, electrolytes, platelets & erythrocytes. 20% & 25%: Not to be diluted w/ water for inj. Ensure adequate hydration. Monitor patients against circulatory overload & hyperhydration.
Sign Out
